Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Adenosine Cyclic 3',5'-Monophosphate-Dependent Protein Kinase and Ornithine Decarboxylase Involvement in the Induction of Cytochrome P-450 and Hepatic Hypertrophy

MAX COSTA, ELIZABETH R. COSTA, CAROL-ANN MANEN, I. GLENN SIPES and DIANE HADDOCK RUSSELL
Molecular Pharmacology September 1976, 12 (5) 871-878;
MAX COSTA
Department of Pharmacology, University of Arizona Medical Center, Tucson, Arizona 85724
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ELIZABETH R. COSTA
Department of Pharmacology, University of Arizona Medical Center, Tucson, Arizona 85724
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CAROL-ANN MANEN
Department of Pharmacology, University of Arizona Medical Center, Tucson, Arizona 85724
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
I. GLENN SIPES
Department of Pharmacology, University of Arizona Medical Center, Tucson, Arizona 85724
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DIANE HADDOCK RUSSELL
Department of Pharmacology, University of Arizona Medical Center, Tucson, Arizona 85724
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The administration of a single dose of Aroclor-1254 (500 mg/kg intraperitoneally) resulted in a biphasic response in rat liver of the activation of cyclic 3',5'-AMP-dependent protein kinase, the induction of ornithine decarboxylase, and the activation of RNA polymerase I. The first cycle of this biphasic response involved activation of cyclic AMP-dependent protein kinase from 2 to 6 hr (177% of control), increased activity of ornithine decarboxylase from 3.5 to 6 hr, and elevation of RNA polymerase I activity from 4 to 6 hr after drug administration. By 8 hr activities of these enzymes had essentially returned to control levels. However, between 10 and 20 hr, cyclic AMP dependent protein kinase activity again rose to about 170% of control, followed by elevated activities of ornithine decarboxylase and RNA polymerase I. The maximal stimulation of ornithine decarboxylase activity was 5-6-fold in both phases of its response, and RNA polymerase I activity was maximal (150% of control) at 5 and 20 hr. Hepatic cytochrome P-450 concentration was increased within 6 hr after a single dose of Aroclor-1254 and reached a maximal concentration of 4 times the control level by 8 days. The liver weight to body weight ratios in rats given the drug were about 150% of control within 2 days and maintained this level through 15 days. Aminophylline and/or dibutyryl cyclic AMP given together with a single low dose of Aroclor-1254 (50 mg/kg) resulted in a greater increase in cytochrome P-450 concentration than did a low dose of Aroclor-1254 administered alone. These data support the concept that the activation of cyclic AMP-dependent protein kinase, elevation of ornithine decarboxylase activity, and enhanced RNA polymerase I activity form a tight temporal sequence of biochemical events that are related to drug-induced liver hypertrophy and to microsomal enzyme induction.

  • Copyright © 1976 by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 12, Issue 5
1 Sep 1976
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Adenosine Cyclic 3',5'-Monophosphate-Dependent Protein Kinase and Ornithine Decarboxylase Involvement in the Induction of Cytochrome P-450 and Hepatic Hypertrophy
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Adenosine Cyclic 3',5'-Monophosphate-Dependent Protein Kinase and Ornithine Decarboxylase Involvement in the Induction of Cytochrome P-450 and Hepatic Hypertrophy

MAX COSTA, ELIZABETH R. COSTA, CAROL-ANN MANEN, I. GLENN SIPES and DIANE HADDOCK RUSSELL
Molecular Pharmacology September 1, 1976, 12 (5) 871-878;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Adenosine Cyclic 3',5'-Monophosphate-Dependent Protein Kinase and Ornithine Decarboxylase Involvement in the Induction of Cytochrome P-450 and Hepatic Hypertrophy

MAX COSTA, ELIZABETH R. COSTA, CAROL-ANN MANEN, I. GLENN SIPES and DIANE HADDOCK RUSSELL
Molecular Pharmacology September 1, 1976, 12 (5) 871-878;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Analgesic Effects and Mechanisms of Licochalcones
  • Induced Fit Ligand Binding to CYP3A4
  • Englerin A Inhibits T-Type Channels
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics